MB

Mark Bobko

BO BOE: 3 patents #4,806 of 12,373Top 40%
AG Aventis Pharma Deutschland Gmbh: 2 patents #137 of 418Top 35%
AP Aventis Pharmaceuticals: 1 patents #232 of 454Top 55%
SA Sanofi-Aventis: 1 patents #630 of 1,008Top 65%
Overall (All Time): #749,634 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
7705151 1,6 Naphthridines useful as inhibitors of SYK kinase Charles Cywin, Scott Jakes, Joachim Heider, Renee L. Des Jarlais, Mark R. Player +3 more 2010-04-27
7678911 1,6 naphthyridines useful as inhibitors of SYK kinase Charles Cywin, Scott Jakes, Joachim Heider, Renee L. Des Jarlais, Mark R. Player +3 more 2010-03-16
7612075 Substituted oxoazaheterocyclyl compounds William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He +16 more 2009-11-03
RE40558 Therapeutic uses of di-aryl acid derivatives Zaid Jayyosi, Gerard McGeehan, Michael Kelley, Richard F. Labaudiniere, Litao Zhang +4 more 2008-10-28
7321041 1,6 Naphthyridines useful as inhibitors of SYK kinase Charles Cywin, Scott Jakes, Joachim Heider, Renee L. Des Jarlais, Mark R. Player +3 more 2008-01-22
7005440 Therapeutic uses of tri-aryl acid derivatives Zaid Jayyosi, Gerard McGeehan, Michael Kelley, Richard F. Labaudiniere, Litao Zhang +5 more 2006-02-28
6635655 Therapeutic uses of di-aryl acid derivatives Zaid Jayyosi, Gerard McGeehan, Michael Kelley, Richard F. Labaudiniere, Litao Zhang +4 more 2003-10-21